Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial
Addiction · 2026-03 · 121 (3) · 575-585
DOI: 10.1111/add.70239 ↗At a glance
Randomisierte kontrollierte Studie in Addiction, published online on 2025-11-11. Written by Jinsong Tang and 9 co-authors. Institution: Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China. Major MEDLINE topics: Smoking Cessation, Mobile Applications, Cognitive Behavioral Therapy. Cited 3 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Shanghai Johnson and Johnson Pharmaceuticals.
Abstract (original language)
Background and aims Smoking is the leading preventable cause of premature death in China, yet less than 10% of smokers seeking to quit receive treatment. This study aimed to test the efficacy of a cognitive behavioral therapy (CBT)‐based smoking cessation intervention (‘Smokefree Life’) via a smartphone app in China.
Design
A digital, parallel, single‐blind, two‐arm (1:1) randomized controlled trial.
Setting
This trial was conducted via ‘Smokefree Life’ app in the whole of mainland of China between 13 December 2021 and 15 April 2023.
Participants
Chinese‐speaking adult smokers (925 males, 102 females, mean age 35.0 ± 6.7) willing to quit within one month were recruited via WeChat, survey sampling and referral from doctors, friends and family and randomized in a 1:1 ratio.
Intervention
The intervention group ( n = 523) received a 13–14 week CBT‐based smoking cessation intervention via smartphone app and the control group ( n = 504) received only control messages. All participants were followed for 26 weeks post‐quit date.
Measurements
The primary outcome was biochemically validated continuous abstinence at 26 weeks. Secondary outcomes were self‐reported 7‐day abstinence and continuous abstinence at 26 weeks.
Findings
By intention‐to‐treat analysis, the biochemically verified 26‐week continuous abstinence rate was statistically significantly higher in the intervention group (6.50%) compared with the control group (2.58%) (odds ratio = 2.63, 95% confidence interval = 1.40–5.22, P = 0.0037). Self‐reported 7‐day and continuous abstinence rates were also consistently higher in the intervention group across follow‐ups (all P < 0.05).
Conclusions
The ‘Smokefree Life’ app‐based smoking cessation intervention statistically significantly improved 6‐month biochemically confirmed quit rates among adult smokers in China.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.
- Department of Big Data in Health Science School of Public Health, Zhejiang University School of Medicine, Zhejiang, China.
- Department of Psychiatry, The Second Xiangya Hospital of Central South University; National Clinical Research Center for Mental Disorders, Changsha, China.
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
ORCID profiles: Yanhui Liao
Funding
- Shanghai Johnson and Johnson Pharmaceuticals
Cite
APA
Tang, J., Liu, X., Chen, S., Sun, Y., Zhu, M., Zhou, Z., Liu, Y., Yang, J., Chen, W., & Liao, Y. (2026). Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial. Addiction, 121(3), 575-585. https://doi.org/10.1111/add.70239
Vancouver
Tang J, Liu X, Chen S, Sun Y, Zhu M, Zhou Z, et al. Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial. Addiction. 2026;121(3):575-585. doi:10.1111/add.70239
BibTeX
@article{Tang2026,
author = {Tang, Jinsong and Liu, Xiaocong and Chen, Shanshan and Sun, Yunkai and Zhu, Minzhe and Zhou, Zitang and Liu, Yueheng and Yang, Jie and Chen, Wei and Liao, Yanhui},
title = {Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial},
journal = {Addiction},
year = {2026},
volume = {121},
number = {3},
pages = {575--585},
doi = {10.1111/add.70239}
}
EUVIMED